Skip to main content
. 2025 Jul 22;17(15):2425. doi: 10.3390/cancers17152425
SRT stereotactic radiotherapy
ICI immune-checkpoint inhibitor
NSCLC non-small cell lung cancer
TP tumour progression
PsP pseudoprogression
RANO-BM response assessment in neuro-oncology brain metastases
WBRT whole-brain-radiotherapy
IQR interquartile range
MPRAGE magnetisation prepared–rapid gradient echo
SPACE sampling perfection with application-optimised contrasts using different flip-angle evolutions
SE spin echo
TFE turbo field echo
OR odds ratio
CR complete response
PR partial response
SD stable disease